1-11 of 11
Agata Tyczynska
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 3 randomized study of teclistamab plus daratumumab versus investigator’s choice of daratumumab and dexamethasone with either pomalidomide or Bortezomib (DPd/DVd) in patients (Pts) with relapsed refractory multiple myeloma (RRMM): Results of majestec-3

Free
María-Victoria Mateos, Nizar Bahlis, Aurore Perrot, Ajay Nooka, Jin Lu, Charlotte Pawlyn, Roberto Mina, Gaston Caeiro, Alain Kentos, Vania Hungria, Donna Reece, Ting Niu, Anne Mylin, Charlotte Hansen, Raphael Teipel, Britta Besemer, Meletios Dimopoulos, Elena Zamagni, Satoshi Yoshihara, Kihyun Kim, Chang-Ki Min, Paulus Geerts, Elena Van Leeuwen-Segarceanu, Agata Tyczynska, Juan Luis Reguera, Magnus Johansson, Markus Hansson, Mehmet Turgut, Mark Grey, Surbhi Sidana, Paula Rodriguez-Otero, Joaquin Martinez-Lopez, Hamza Hashmi, Robin Carson, Rachel Kobos, Weili Sun, Kristen Lantz, Anne Seifert, Debbie Briseno-Toomey, Lisa O'Rourke, Maria Rubin, Diego Vieyra, Lijuan Kang, Luciano Costa
Journal: Blood
Blood (2025) 146 (Supplement 2): LBA-6.
https://doi.org/10.1182/blood-2025-LBA-6
Published: 2025
Journal Articles

Real-world efficacy and safety of teclistamab in relapsed or refractory multiple myeloma: Results from 87 patients treated by the polish myeloma group

Free
Grzegorz Charlinski, Jacek Krzanowski, Dominik Gorzelak, Agata Tyczynska, Lukasz Szukalski, Magdalena Olszewska-Szopa, Pawel Steckiewicz, Sylwia Trzpiot, Agnieszka Druzd-Sitek, Jaroslaw Grzyb, Anna Kopinska, Agnieszka Szymczyk, Boguslaw Machalinski, Elzbieta Wiater, Michał Mielnik, Marek Rodzaj, Marek Hus, David Vesole, Artur Jurczyszyn
Journal: Blood
Blood (2025) 146 (Supplement 1): 5838.
https://doi.org/10.1182/blood-2025-5838
Published: 2025
Journal Articles

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide and dexamethasone (VRd) in patients with newly diagnosed multiple myeloma (NDMM) – interim results from the randomized Phase III COBRA trial.

Free
Dominik Dytfeld, Tadeusz Kubicki, Agata Tyczynska, Marcin Rymko, Krzysztof Jamroziak, Fredrik Schjesvold, Jaroslaw Piszcz, Tomasz Wrobel, Krzysztof Giannopoulos, Bartosz Pula, Agnieszka Konska, Pawel Steckiewicz, Juha Lievonen, Mateusz Ziarkiewicz, Pawel Bernatowicz, Lidia Gil, Anna Lojko-Dankowska, Magdalena Matuszak, Jan Zaucha, Maria Czyzewska, Kamil Wisniewski, Magdalena Olszewska-Szopa, Anna Pula, Frank Wen, Frida Bugge Askeland, Valdas Peceliunas, Jennifer Cooperrider, Ken Jiang, Theodore Karrison, Benjamin Derman, Andrzej Jakubowiak
Journal: Blood
Blood (2025) 146 (Supplement 1): 99.
https://doi.org/10.1182/blood-2025-99
Published: 2025
Journal Articles

Mass spectrometry–based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma

Free
Clinical Trials & Observations
Tadeusz Kubicki, Dominik Dytfeld, David Barnidge, Dhananjay Sakrikar, Anna Przybyłowicz-Chalecka, Krzysztof Jamroziak, Paweł Robak, Jarosław Czyż, Agata Tyczyńska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wróbel, Adam Nowicki, Tomasz Szczepaniak, Anna Łojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Puła, Łukasz Szukalski, Agnieszka Końska, Jan Maciej Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Ken Jiang, Jennifer H. Cooperrider, Andrzej J. Jakubowiak, Benjamin A. Derman
Journal: Blood
Blood (2024) 144 (9): 955–963.
https://doi.org/10.1182/blood.2024024041
Published: 2024
Includes: Supplemental data
Journal Articles

Mass Spectrometry-Based Assessment of M-Protein in Peripheral Blood during Maintenance Therapy in Multiple Myeloma (MM) in the Phase III ATLAS Trial

Free
Tadeusz Kubicki, Dominik Dytfeld, David Barnidge, DJ Sakrikar, Gabriella Lakos, Anna Przybylowicz-Chalecka, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wrobel, Adam Nowicki, Tomasz Szczepaniak, Anna Lojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Michal Pula, Lukasz Szukalski, Agnieszka Konska, Jan M. Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Ken Jiang, Jennifer H Cooperrider, Andrzej J Jakubowiak, Benjamin A Derman
Journal: Blood
Blood (2023) 142 (Supplement 1): 340.
https://doi.org/10.1182/blood-2023-190209
Published: 2023
Journal Articles

Health-Related Quality of Life in Polish Patients with Multiple Myeloma Treated in the Phase 3 ATLAS Trial of Post-Transplant Maintenance with Carfilzomib, Lenalidomide, Dexamethasone or Lenalidomide Alone

Free
Tadeusz Kubicki, Ben A Derman, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Tomasz Wrobel, Adam Nowicki, Tomasz Szczepaniak, Anna Lojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Michal Pula, Lukasz Szukalski, Agnieszka Konska, Jan M. Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Dorota Kruk-Kwapisz, Andrzej J Jakubowiak, Dominik Dytfeld
Journal: Blood
Blood (2023) 142 (Supplement 1): 3344.
https://doi.org/10.1182/blood-2023-189537
Published: 2023
Journal Articles

Longitudinal Assessment of Minimal Residual Disease (MRD) in the ATLAS Randomized Phase 3 Trial of Post-Transplant Treatment with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Versus Lenalidomide (R) Alone in Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Free
Tadeusz Kubicki, Dominik Dytfeld, Tomasz Wrobel, Krzysztof Jamroziak, Pawel Robak, Jaroslaw Czyz, Agata Tyczynska, Agnieszka Druzd-Sitek, Krzysztof Giannopoulos, Adam Nowicki, Tomasz Szczepaniak, Anna Lojko-Dankowska, Magdalena Matuszak, Lidia Gil, Bartosz Michal Pula, Justyna Rybka, Maciej Majcherek, Lidia Usnarska-Zubkiewicz, Lukasz Szukalski, Agnieszka Konska, Jan M. Zaucha, Jan Walewski, Damian Mikulski, Olga Czabak, Tadeusz Robak, Dorota Kruk-Kwapisz, Oscar Boutros Lahoud, Jeffrey A. Zonder, Kent Griffith, Andrew T Stefka, Ken Jiang, Jennifer H Cooperrider, Ben A Derman, Andrzej J Jakubowiak
Journal: Blood
Blood (2023) 142 (Supplement 1): 4715.
https://doi.org/10.1182/blood-2023-189850
Published: 2023
Journal Articles

The Outcome of the First-Line Therapy of Patients with Follicular Lymphoma during COVID-19 Pandemic. a Real-World Data from the Polish Lymphoma Research Group (PLRG)

Free
Ewa Paszkiewicz-Kozik, Monika Palka, Malgorzata Debowska, Marcin Szymanski, Agnieszka Konska, Elzbieta Kalicinska, Agata Tyczynska, Joanna Drozd-Sokolowska, Agnieszka Giza, Ryszard Swoboda, Anna Paulina Dabrowska-Iwanicka, Marta Morawska, Justyna Owczarek-Kaczmarek, Lukasz Bolkun, Anna Kopinska, Ewa Wasik-Szczepanek, Dominika Maksylewicz, Anna Wisniewska, Lukasz Targonski, Edyta Subocz, Pawel Steckiewicz, Katarzyna Domanska-Czyz, Beata Ostrowska, Monika Swierkowska, Jacek Krzanowski, Agnieszka Druzd-Sitek, Ewa Mroz-Zycinska, Joanna Romejko-Jarosinska, Iwona Hus, Monika Dlugosz-Danecka, Ewa Lech-Maranda, Tomasz Wrobel, Jan M. Zaucha, Jan Walewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 1679.
https://doi.org/10.1182/blood-2023-186945
Published: 2023
Journal Articles

Safety and Early Efficacy of Obinutuzumab in Combination with Chemotherapy in Treatment Naive Patients with Follicular Lymphoma - Report of Polish Lymphoma Research Group (PLRG)

Free
Ewa Paszkiewicz-Kozik, Iwona Hus, Monika Palka, Malgorzata Debowska, Agnieszka Konska, Martyna Kotarska, Agata Tyczynska, Monika Joks, Maja Twardosz, Agnieszka Giza, Ewa Wasik-Szczepanek, Elzbieta Kalicinska, Anna Wisniewska, Marta Morawska, Joanna Romejko-Jarosinska, Barbara Lewicka, Lukasz Targonski, Michal Osowiecki, Lidia Poplawska, Marcin Szymanski, Kamila Kruczkowska-Taranowicz, Joanna Drozd-Sokolowska, Ryszard Swoboda, Katarzyna Domanska-Czyz, Beata Ostrowska, Monika Swierkowska, Anna Paulina Dabrowska-Iwanicka, Agnieszka Druzd-Sitek, Robert Konecki, Anna Borawska, Monika Dlugosz-Danecka, Ewa Lech-Marańda, Jan Walewski
Journal: Blood
Blood (2021) 138 (Supplement 1): 4525.
https://doi.org/10.1182/blood-2021-145534
Published: 2021
Journal Articles

Early Mortality in Patients with Multiple Myeloma Treated with Novel Agents - Analysis from Polish Myeloma Study Group

Free
Grzegorz Charlinski, MDPhD, Agata Tyczyńska, MD, Jan M Zaucha, MD PhD, Adriana Czyz, MD, Jarosław Czyż, MDPhD, Dominik Dytfeld, MDPhD, Bartosz Malecki, MD, Lidia Gil, MDPhD, Szymon Fornagiel, MD, Sebastian Grosicki, MD PhD, Agnieszka Barchnicka, MD, Jadwiga Holojda, MD, Agnieszka Kolkowska, MD PhD, Iwona Hus, MD PhD, Grzegorz Helbig, MDPhD, Anna Kopinska, MD, Anna Masternak, MD, Dariusz Woszczyk, MDPhD, Miroslaw Markiewicz, MDPhD, Jaroslaw Piszcz, MDPhD, Janusz Kloczko, MDPhD, Lidia Usnarska-Zubkiewicz, MDPhD, Tomasz Wrobel, MD PhD, Pawel J. Robak, MDPhD, Tadeusz Robak, MDPhD, Anna Waszczuk-Gajda, MD, Grzegorz Basak, MD PhD, Artur Jurczyszyn, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-143003
Published: 2020
Journal Articles

Bendamustine, Gemcitabine and Dexamethasone Chemotherapy Is Effective Salvage and Stem-Cell Mobilization Regimen in Patients with Relapsed or Refractory Hodgkin Lymphoma — Early Results of the Polish Lymphoma Research Group Study

Free
Ewa Paszkiewicz-Kozik, Jan Zaucha, MD PhD, Agata Tyczyńska, MD, Marcin Szymanski, MD, Lukasz Targonski, MD, Joanna Drozd-Sokolowska, MD PhD, Elżbieta Wojciechowska-Lampka, MD, Joanna Tajer, MD PhD, Pawel Kurczab, MD, Joanna Romejko-Jarosinska, MD PhD, Michal Osowiecki, MD, Jan Walewski, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4098.
https://doi.org/10.1182/blood.V130.Suppl_1.4098.4098
Published: 2017